Christopher Amos, PhD, will join The University of New Mexico Comprehensive Cancer Center on October 1, Yolanda Sanchez, PhD, announced. Sanchez leads the UNM Comprehensive Cancer Center as Director and CEO. Amos will serve as Associate Director for Population Sciences and Cancer Control at the UNM Cancer Center and will also serve as Director of the UNM Health Sciences Center (HSC) Data Science Initiative.
The University of New Mexico Comprehensive Cancer Center has opened a clinical trial that applies hyperthermic intraperitoneal chemotherapy (HIPEC) — a proven surgical technique that is used in digestive system cancers — to ovarian cancer.
The University of New Mexico Comprehensive Cancer Center has opened a clinical trial that applies hyperthermic intraperitoneal chemotherapy (HIPEC) — a proven surgical technique that is used in digestive system cancers — to ovarian cancer.
Early natural menopause (early-M; <45 years of age) increases the risk of lung morbidities and mortalities in smokers. However, it is largely unknown whether early-M due to surgery demonstrates similar effects and whether menopausal hormone therapy (MHT) is protective against lung diseases.
In 2022, Alaggio and colleagues revised the WHO Classification of Haematolymphoid Tumors resulting in elimination of the provisional diagnostic categories of Hairy Cell Leukemia Variant (HCLv) and B Prolymphocytic Leukemia.
The University of New Mexico Comprehensive Cancer Cancer Center achieves accreditation for radiation oncology services from the American Society for Radiation Oncology APEx - Accreditation Program for Excellence
In Greek mythology, a Chimera is a creature of change, a being possessing the forms of lion, goat and dragon. But unlike the mythical creature, a new approach to fighting cancer cells throughout the body is very real and has arrived at The University of New Mexico Comprehensive Cancer Center.
The UNM Comprehensive Cancer Center is partnering with Northern Arizona University, New Mexico State University and the Burrell College of Osteopathic Medicine, which is located on NMSU’s campus in Las Cruces, to connect emerging cancer disparities researchers with mentors to continue developing these scholars.
Over the last two decades, strides in cancer prevention, earlier detection, and novel treatments have reduced overall cancer mortality; however, cancer health disparities (CHD) persist among demographically diverse and intersecting populations.
A cancer diagnosis scares most people. Those outside of large population centers like Albuquerque have the additional concern of having to travel to get timely, specialized medical treatment. Now, a new program at The University of New Mexico Comprehensive Cancer Center aims to streamline the process for all New Mexicans, regardless of where they live in the state.
A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the US, relative to overall screening rates in the country.
The UNM Comprehensive Center is expanding a program aimed at encouraging young people to explore research as a career field. In addition to a first-ever middle school component, the program is adding more opportunities for high school and undergraduates to get real world lab and research experience.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
